Table 5.
Association between clinicopathologic characteristics and HCC patient PFI through univariate and multivariate analysis with Cox regression survival model
| Characteristics | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95%CI | P-value | HR | 95%CI | P-value | |
| CDK6 (high vs. low) | 0.7 | 0.4–1.1 | 0.082 | 0.7 | 0.4–1.1 | 0.119 |
| RB1 expression (high vs. low) | 0.8 | 0.5–1.3 | 0.374 | 1.4 | 0.8–2.5 | 0.185 |
| Age (>40 vs. ≤ 40) | 0.7 | 0.4–1.3 | 0.268 | 1.0 | 0.5–2.1 | 0.959 |
| Gender (male vs. female) | 0.7 | 0.5–1.2 | 0.239 | 0.9 | 0.5–1.6 | 0.747 |
| Alcohol consumption (yes vs. no) | 0.9 | 0.5–1.6 | 0.804 | |||
| Histologic grade (G3–4 vs. G1–2) | 1.4 | 1.0–1.9 | 0.061 | 1.2 | 0.9–1.7 | 0.270 |
| M (M1 vs. M0) | 4.9 | 0.7–36.2 | 0.118 | 0.7 | 0.1–6.8 | 0.735 |
| N (N1 vs. N0) | 3.4 | 0.5–24.6 | 0.230 | 0.8 | 0.0–89.4 | 0.925 |
| T (T3–4 vs. T1–2) | 1.5 | 1.2–2.0 | 0.001 | 0.7 | 0.1–5.6 | 0.748 |
| Clinical stage (III-IV vs. I-II) | 1.6 | 1.2–2.1 | 0.000 | 2.2 | 0.3–18.6 | 0.458 |
| Postoperative ablation embolization (yes vs. no) | 2.8 | 1.5–5.2 | 0.001 | 3.7 | 1.8–7.9 | 0.001 |
| Radiation therapy (yes vs. no) | 1.3 | 0.2–9.3 | 0.806 | |||
| Family history of cancer (yes vs. no) | 1.2 | 0.7–2.0 | 0.445 | 1.1 | 0.6–1.9 | 0.732 |
| Vascular invasion (yes vs. no) | 1.4 | 0.8–2.2 | 0.228 | 1.2 | 0.7–2.0 | 0.579 |
| E2F2 (high vs. low) | 1.8 | 1.2–2.6 | 0.005 | 2.2 | 1.3–3.9 | 0.005 |
PFI Progression-free interval, T = topography distribution, N = lymph node metastasis, M = distant metastasis, CI Confidence interval